Compare AVXL & HMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | HMH |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil and Gas Field Machinery |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 237.2M |
| IPO Year | 2013 | 2024 |
| Metric | AVXL | HMH |
|---|---|---|
| Price | $1.51 | $18.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $28.71 |
| AVG Volume (30 Days) | ★ 1.1M | 204.7K |
| Earning Date | 11-24-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.81 |
| P/E Ratio | ★ N/A | $14.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $16.87 |
| 52 Week High | $9.50 | $22.34 |
| Indicator | AVXL | HMH |
|---|---|---|
| Relative Strength Index (RSI) | 20.06 | 46.31 |
| Support Level | N/A | $18.30 |
| Resistance Level | $2.80 | $20.16 |
| Average True Range (ATR) | 0.13 | 0.89 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 6.06 | 56.91 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
HMH Holding Inc is a provider of offshore and onshore drilling equipment and services in the United States and Norway. Its services include sales of projects and products including drilling equipment packages for newbuild or a reactivated drilling rig, and individual or grouped components of drilling and pressure control equipment. The company also offers aftermarket services including services and replacement parts on installed equipment and integrated digital solutions. The company sells equipment and services to drilling contractors; operators, including both oil and gas E&P companies and mining companies onshore and offshore; and manufacturers, consisting of shipyards.